EMBL Science Day with Evonik: fostering collaborative innovations
EMBL hosted a Science Day with Evonik, bringing together 16 industry experts and EMBL scientists to explore collaborative research opportunities.
CONNECTIONS2024
connections
IIT-EMBL: New molecules to modulate gene expression
A new research paper published in Nature Communications lays the groundwork for the development of new drugs specific to genetic mutations or alterations responsible for the onset of tumours or genetic diseases.
SCIENCE & TECHNOLOGY2024
science-technology
Inaugural ‘From Lab to Launch’ event ignites entrepreneurial spirit among scientists
This event bridged research and entrepreneurship, fuelling innovation and discovery. Attendees immersed themselves in insightful discussions and invaluable networking opportunities, inspired to journey from lab research to entrepreneurial success.
CONNECTIONS2024
connections
An epigenome editing toolkit to dissect the mechanisms of gene regulation
A study from the Hackett group at EMBL Rome led to the development of an epigenetic editing system that allows to precisely program chromatin modifications at any specific position in the genome, to understand their causal role in transcription regulation.
SCIENCE & TECHNOLOGY2024
science-technology
The power of cell sorting: understanding heart disease, phase separation, plankton, and more
EMBL researchers use a new cell sorting technology to gain new insights into cellular function in health and disease, as well as for other innovative applications.
SCIENCE & TECHNOLOGY2023
sciencescience-technology
We are EMBL: Jürgen Bauer on translating ideas into applications
Jürgen Bauer talks about translating science into applications with societal benefit, his journey from the lab bench to business development, and technology transfer at EMBL.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectives
IMAGINE-ing next-generation technology to help biologists
EMBL researchers and collaborators have begun an impactful innovation-development journey, thanks to a European Commission ‘IMAGINE’ grant.
CONNECTIONSLAB MATTERS2023
connectionslab-matters
Vizgen joins EMBL science-industry programme
Vizgen, the life science company dedicated to improving human health by visualising single-cell spatial genomics information, has joined EMBL’s Corporate Partnership Programme.
CONNECTIONSLAB MATTERS2023
connectionslab-matters
New EU-funded Project: Fragment-Screen
EMBL is one of the partners of this project that aims to accelerate drug discovery and development, bringing in expertise from EMBL Grenoble and EMBL-EBI.
LAB MATTERSSCIENCE & TECHNOLOGY2023
lab-mattersscience-technology
Promoting European innovation in the life sciences
One of EMBL’s core missions is the development and transfer of scientific know-how and technologies to academia, industry, and commercial entities to facilitate further research, innovations, and commercialisation for the benefit of society at large. Working across Europe, EMBL has partnerships…
CONNECTIONSLAB MATTERS2023
connectionslab-matters
Teamed up to innovate
A new formal collaboration agreement enables will help smooth the transition from fundamental science to innovation.
CONNECTIONSLAB MATTERS2022
connectionslab-matters
Investing in Italy by translating EMBL expertise to the market
Experiences at EMBL Rome led former group leader to establish his start-up in Italy, developing a new generation of gene therapies.
LAB MATTERSSCIENCE & TECHNOLOGY2022
alumnilab-mattersscience-technologytechnology-and-innovation
Cell sorting enters a new dimension
EMBL researchers, in collaboration with BD Biosciences, have demonstrated a new technology that allows rapid image-based sorting of cells. The new technology represents a major upgrade to flow cytometry and has applications in diverse life science fields.
SCIENCE & TECHNOLOGY2022
sciencescience-technology
Celebrating Lithuania-EMBL cooperation on life science research
EMBL has taken another step towards strengthening its scientific relationship with Lithuania.
CONNECTIONS2021
connectionsevents
Structural biology at EMBL: driving technology development
Florent Cipriani, who recently retired as Head of the Instrumentation Team after a long career at EMBL Grenoble, is one of the pioneers of instrumentation development in this field.
LAB MATTERSSCIENCE & TECHNOLOGY2021
lab-mattersscience-technology
Antibody engineering for therapy and diagnosis
The new EMBL spinoff company Araxa Biosciences GmbH aims to set new standards for the development of antibody-based therapeutics and diagnostics
LAB MATTERSSCIENCE & TECHNOLOGY2020
lab-mattersscience-technology
Twenty years of EMBLEM
Reflecting on 20 years of EMBLEM
LAB MATTERS2019
lab-matters
Welcome: Sarah Butcher
Building bridges between scientists and software developers
LAB MATTERS2018
lab-matters
EMBL spin-off Luxendo acquired by Bruker
Accelerating researchers’ access to next-generation light-sheet microscopy
CONNECTIONSLAB MATTERS2017
connectionslab-matters
SPIM doctors
From initial development to a start-up company: Selective Plane Illumination Microscopy (SPIM) at EMBL.
SCIENCE & TECHNOLOGY2015
sciencescience-technology
Lighting the way
A microscopy technique is poised to shine new light on biological questions: as sheets of light can scan everything from developing embryos to single cells or functioning brains, a technique called light-sheet microscopy is gaining traction. It enables scientists to observe living cells in three…
LAB MATTERSSCIENCE & TECHNOLOGY2015
lab-mattersscience-technology
Decoding disease
Behind the scenes of start-up Miroculus, developing a non-invasive test for early-stage disease.
SCIENCE & TECHNOLOGY2015
alumniscience-technology
No results found